Study Title: A Randomized Phase II Study Comparing Inotuzumab plus Chemotherapy versus Standard Chemotherapy in Older Adults with Philadelphia Chromosome Negative B Cell Acute Lymphoblastic Leukemia (ALL)
For more information about the trial above please contact the study team:Medical University of South CarolinaPrincipal Investigator, Coltoff, Alexander, at coltoff@musc.edu.Study Coordinator, Baker, Hana, at bakerhan@musc.edu.Trial opened at the following institutions: Medical University of South Carolina